Recognition of loss on retirement of fixed assets such as medical instruments
First written in FY2019-Q3. . Latest entry: FY2026.
78 other companies' latest entry also says "Other".
- FY2026Full-year recognition of losses on disposal of fixed assetsAnnual report
「As a result of recording ¥32 million in losses on the disposal of fixed assets, including medical instruments, and ¥7 million in losses related to the discontinuation of product sales as extraordinary losses, profit attributable to owners of the parent was ¥263 million.」
¥32 million in losses on disposal of medical instruments and other fixed assets was recorded for the full year, continuing from prior fiscal years. - FY2026-H1Interim-period recognition of losses on disposal of fixed assetsAnnual report
「As a result of recording ¥14 million in losses on disposal of medical instruments and other fixed assets and ¥7 million in losses related to the discontinuation of product sales as extraordinary losses, interim net income attributable to owners of the parent was ¥69 million, down 85.9% year on year.」
¥14 million in losses on disposal of medical instruments and other fixed assets was recorded as an extraordinary loss, continuing from prior fiscal years. - FY2025-H1Interim-period recognition of losses on disposal of fixed assetsAnnual report
「As a result of recording ¥22 million in losses on disposal of medical instruments and other fixed assets as an extraordinary loss, interim net income attributable to owners of the parent was ¥496 million, up 38.0% year on year.」
¥22 million in losses on disposal of medical instruments and other fixed assets was recorded as an extraordinary loss for the interim period. - FY2024Full-year recognition of losses on disposal of fixed assetsAnnual report
「Extraordinary items included ¥72 million in impairment losses on investment securities, ¥48 million in losses on disposal of medical instruments and other fixed assets, and ¥75 million in settlement-related expenses incurred in the first quarter, among other items totaling ¥206 million recorded as an extraordinary loss.」
¥48 million in losses on disposal of medical instruments and other fixed assets was recorded for the full year, continuing from prior fiscal years. - FY2024-Q3Increase in cumulative losses recorded on disposal of fixed assetsAnnual report
「Extraordinary items included ¥29 million in losses on disposal of medical instruments and other fixed assets and ¥75 million in settlement-related expenses incurred in the first quarter, totaling ¥104 million recorded as an extraordinary loss.」
Losses on disposal of medical instruments and other fixed assets increased from ¥18 million for the six-month period to ¥29 million for the nine-month period, increasing the cumulative amount recorded. - FY2024-Q2Increase in cumulative losses recorded on disposal of fixed assetsAnnual report
「Extraordinary items included ¥18 million in losses on disposal of medical instruments and other fixed assets and ¥75 million in settlement-related expenses incurred in the first quarter, totaling ¥93 million recorded as an extraordinary loss.」
Losses on disposal of medical instruments and other fixed assets increased from ¥9 million through the first quarter to ¥18 million for the six-month period. - FY2024-Q1Continued recognition of losses on disposal of fixed assets, including medical instrumentsAnnual report
「Extraordinary items included ¥9 million in losses on disposal of medical instruments and other fixed assets and ¥75 million in settlement-related expenses, totaling ¥84 million recorded as an extraordinary loss.」
¥9 million in losses on disposal of medical instruments and other fixed assets was recorded as an extraordinary loss, continuing from prior fiscal years. - FY2023-Q3Continued recognition of losses on disposal of fixed assets, including medical instrumentsAnnual report
「Extraordinary items included ¥25 million in compensation received and ¥19 million in reversal of provision for business losses, totaling ¥44 million recorded as extraordinary income, and ¥47 million in losses on disposal of medical instruments and other fixed assets, recorded as an extraordinary loss.」
¥47 million in losses on disposal of medical instruments and other fixed assets was recorded as an extraordinary loss, continuing from prior fiscal years. - FY2023-Q2Continued recognition of losses on disposal of fixed assets, including medical instrumentsAnnual report
「Extraordinary items included ¥25 million in compensation received and ¥12 million in reversal of provision for business losses, totaling ¥37 million recorded as extraordinary income, and ¥21 million in losses on disposal of medical instruments and other fixed assets, recorded as an extraordinary loss.」
¥21 million in losses on disposal of medical instruments and other fixed assets was recorded as an extraordinary loss, continuing from prior fiscal years. - FY2023-Q1Continued recognition of losses on disposal of fixed assets, including medical instrumentsAnnual report
「Extraordinary items included ¥6 million in reversal of provision for business losses, recorded as extraordinary income, and ¥12 million in losses on disposal of medical instruments and other fixed assets, recorded as an extraordinary loss.」
¥12 million in losses on disposal of medical instruments and other fixed assets was recorded as an extraordinary loss, continuing from prior fiscal years. - FY2022-Q3Increase in cumulative losses recorded on disposal of fixed assetsAnnual report
「Extraordinary items included ¥306 million in gain on debt forgiveness arising in the United States, recorded as extraordinary income, and ¥62 million in losses on disposal of medical instruments and other fixed assets, recorded as an extraordinary loss.」
Losses on disposal of medical instruments and other fixed assets totaled ¥62 million for the nine-month period, increasing the cumulative amount from the recognition through the previous quarter. - FY2022-Q2Continued recognition of losses on disposal of fixed assets, including medical instrumentsAnnual report
「Extraordinary items included ¥303 million in gain on debt forgiveness arising in the United States, recorded as extraordinary income, and ¥20 million in losses on disposal of medical instruments and other fixed assets, recorded as an extraordinary loss.」
¥20 million in losses on disposal of medical instruments and other fixed assets was recorded as an extraordinary loss, continuing the recognition through the previous quarter. - FY2022-Q1Continued recognition of losses on disposal of fixed assets, including medical instrumentsAnnual report
「Extraordinary items included ¥11 million in losses on disposal of medical instruments and other fixed assets, recorded as an extraordinary loss.」
¥11 million in losses on disposal of medical instruments and other fixed assets was recorded as an extraordinary loss, continuing from the previous fiscal year. - FY2021-Q3Continued recognition of losses on disposal of fixed assets, including medical instrumentsAnnual report
「Extraordinary items included ¥28 million in losses on disposal of medical instruments and other fixed assets, recorded as an extraordinary loss.」
Losses on disposal of medical instruments and other fixed assets were also recorded for the nine-month period, confirming continued recognition. - FY2021-Q2Continued recognition of losses on disposal of fixed assets, including medical instrumentsAnnual report
「Extraordinary items included ¥17 million in losses on disposal of medical instruments and other fixed assets, recorded as an extraordinary loss.」
¥17 million in losses on disposal of medical instruments and other fixed assets was recorded as an extraordinary loss, continuing the recognition from the previous quarter. - FY2021-Q1Continued recognition of losses on disposal of fixed assets, including medical instrumentsAnnual report
「Extraordinary items included ¥8 million in losses on disposal of medical instruments and other fixed assets, recorded as an extraordinary loss.」
¥8 million in losses on disposal of medical instruments and other fixed assets was recorded as an extraordinary loss, confirming continued recognition. - FY2020Full-year recognition of losses on disposal of medical instruments and other fixed assetsAnnual report
「In addition, ¥35 million in losses on disposal of medical instruments and other fixed assets was recorded as an extraordinary loss for the full year.」
¥35 million in losses on disposal of medical instruments and other fixed assets was recorded for the full year. - FY2020-Q3Continued recognition of losses on disposal of fixed assets, including medical instrumentsAnnual report
「In addition, ¥26 million in losses on disposal of medical instruments and other fixed assets was recorded as an extraordinary loss for the nine-month period of the fiscal year under review.」
¥26 million in losses on disposal of medical instruments and other fixed assets was recorded as an extraordinary loss, continuing the recognition reported in the previous quarterly report. - FY2020-Q2Continued recognition of losses on disposal of fixed assets, including medical instrumentsAnnual report
「Under extraordinary income and losses, compensation received for damage to consigned inventory held by a US customer of ¥103 million was recognized as an extraordinary gain, while losses on disposal of fixed assets, including medical instruments, of ¥17 million and a litigation settlement payment at a US subsidiary of ¥33 million were recognized as extraordinary losses.」
Losses on disposal of fixed assets, including medical instruments, of ¥17 million were recognized as an extraordinary loss, continuing the recognition reported in the previous disclosure. - FY2020-Q1Continued recognition of losses on disposal of fixed assets, including medical instrumentsAnnual report
「Under extraordinary income and losses, losses on disposal of fixed assets, including medical instruments, of ¥7 million were recognized as an extraordinary loss.」
Losses on disposal of fixed assets, including medical instruments, of ¥7 million were recognized as an extraordinary loss. - FY2019-Q3First statedAnnual report
「Under extraordinary income and losses, losses on disposal of fixed assets, including medical instruments, of ¥28 million were recognized as an extraordinary loss.」
During the nine months ended 31 December, losses on disposal of fixed assets, including medical instruments, of ¥28 million were recognized as an extraordinary loss.